{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T05:48:08Z","timestamp":1762926488707,"version":"3.40.3"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2014,6,20]],"date-time":"2014-06-20T00:00:00Z","timestamp":1403222400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2014,6,20]],"date-time":"2014-06-20T00:00:00Z","timestamp":1403222400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Folia Microbiol"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1007\/s12223-014-0328-0","type":"journal-article","created":{"date-parts":[[2014,6,19]],"date-time":"2014-06-19T16:12:44Z","timestamp":1403194364000},"page":"515-521","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Cryptococcus neoformans meningoencephalitis in a patient with polyarteritis nodosa"],"prefix":"10.1007","volume":"59","author":[{"given":"Vladim\u00edr","family":"Buchta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petr","family":"Pr\u00e1\u0161il","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcela","family":"Vejsov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roman","family":"Mottl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Radka","family":"Kutov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcela","family":"Draho\u0161ov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stanislav","family":"Pl\u00ed\u0161ek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,6,20]]},"reference":[{"key":"328_CR1","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1128\/AAC.44.6.1544-1548.2000","volume":"44","author":"AI Aller","year":"2000","unstructured":"Aller AI, Martin-Mazuelos E, Lozano F et al (2000) Correlation of fluconazole MICs with clinical outcome in cryptococcal infection. Antimicrob Agents Chemother 44:1544\u20131548","journal-title":"Antimicrob Agents Chemother"},{"key":"328_CR2","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1179\/joc.2009.21.1.108","volume":"21","author":"R Bandettini","year":"2009","unstructured":"Bandettini R, Castagnola E, Calvillo M et al (2009) Voriconazole for cryptococcal meningitis in children with leukemia or receiving allogeneic hemopoietic stem cell transplant. J Chemother 21:108\u2013109","journal-title":"J Chemother"},{"key":"328_CR3","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1111\/j.1600-0463.2007.apm_513.x","volume":"115","author":"P Bene\u0161ov\u00e1","year":"2007","unstructured":"Bene\u0161ov\u00e1 P, Buchta V, Cerman J, \u017d\u00e1k P (2007) Cryptococcosis-a review of 13 autopsy cases from a 54-year period in a large hospital. APMIS 115:177\u2013183","journal-title":"APMIS"},{"key":"328_CR4","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1046\/j.1365-2796.1996.447785000.x","volume":"240","author":"G Bordin","year":"1996","unstructured":"Bordin G, Ballar\u00e9 M, Paglino S et al (1996) Idiopathic CD4+ lymphocytopenia and systemic vasculitis. J Intern Med 240:37\u201341","journal-title":"J Intern Med"},{"key":"328_CR5","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/S0213-005X(06)73780-6","volume":"24","author":"M Ch\u00e1vez-L\u00f3pez","year":"2006","unstructured":"Ch\u00e1vez-L\u00f3pez M, M\u00e1rquez-D\u00edaz F, Aguayo-Leytte G (2006) Meningitis criptoc\u00f3cica tras tratamiento con etanercept. Enferm Infecc Microbiol Clin 24:288","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"328_CR6","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1093\/rheumatology\/kel343","volume":"46","author":"HS Chen","year":"2007","unstructured":"Chen HS, Tsai WP, Leu HS, Ho HH, Liou LB (2007) Invasive fungal infection in systemic lupus erythematosus: an analysis of 15 cases and a literature review. Rheumatology (Oxford) 46:539\u2013544","journal-title":"Rheumatology (Oxford)"},{"key":"328_CR7","doi-asserted-by":"publisher","first-page":"261","DOI":"10.3109\/13693786.2012.715763","volume":"51","author":"JW Cheong","year":"2013","unstructured":"Cheong JW, McCormack J (2013) Fluconazole resistance in cryptococcal disease: emerging or intrinsic? Med Mycol 51:261\u2013269","journal-title":"Med Mycol"},{"key":"328_CR8","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1128\/AAC.39.8.1671","volume":"39","author":"TW Chin","year":"1995","unstructured":"Chin TW, Loeb M, Fong IW (1995) Effects of an acidic beverage (Coca-Cola) on absorption of ketoconazole. Antimicrob Agents Chemother 39:1671\u20131675","journal-title":"Antimicrob Agents Chemother"},{"key":"328_CR9","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s10096-007-0430-1","volume":"27","author":"YM Chuang","year":"2008","unstructured":"Chuang YM, Ho YC, Chang HT, Yu CJ, Yang PC, Hsueh PR (2008) Disseminated cryptococcosis in HIV-uninfected patients. Eur J Clin Microbiol Infect Dis 27:307\u2013310","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"328_CR10","unstructured":"Clinical and Laboratory Standards Institute (2002) Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard. Second edition, document M27-A2. CSLI, Wayne, Pa"},{"key":"328_CR11","unstructured":"Clinical and LaboratoryStandards Institute (2004) Method for antifungal disk diffusion susceptibility testing of yeasts. Approved guideline M44-A. CSLI, Wayne, Pa"},{"key":"328_CR12","unstructured":"Clinical and LaboratoryStandards Institute (2012) Reference method for broth dilution antifungal susceptibility testing of yeasts; Forth informational Supplement, CSLI document M27-S4"},{"key":"328_CR13","doi-asserted-by":"publisher","first-page":"2464","DOI":"10.1128\/AAC.01520-05","volume":"50","author":"E Dannaoui","year":"2006","unstructured":"Dannaoui E, Abdul M, Arpin M et al (2006) Results obtained with various antifungal susceptibility testing methods do not predict early clinical outcome in patients with cryptococcosis. Antimicrob Agents Chemother 50:2464\u20132470","journal-title":"Antimicrob Agents Chemother"},{"key":"328_CR14","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1056\/NEJMoa1110404","volume":"368","author":"JN Day","year":"2013","unstructured":"Day JN, Chau TT, Wolbers M et al (2013) Combination antifungal therapy for cryptococcal meningitis. N Engl J Med 368:1291\u20131302","journal-title":"N Engl J Med"},{"key":"328_CR15","doi-asserted-by":"crossref","unstructured":"Duperval R, Hermans PE, Brewer NS, Roberts GD (1977) Cryptococcosis, with emphasis on the significance of isolation of Cryptococcus neoformans from the respiratory tract. Chest 72:13--19","DOI":"10.1378\/chest.72.1.13"},{"key":"328_CR16","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1128\/JCM.00064-13","volume":"51","author":"X Feng","year":"2013","unstructured":"Feng X, Fu X, Ling B, Wang L, Liao W, Yao Z (2013) Development of a singleplex PCR assay for rapid identification and differentiation of Cryptococcus neoformans var. grubii, Cryptococcus neoformans var. neoformans, Cryptococcus gattii, and hybrids. J Clin Microbiol 51:1920\u20131923","journal-title":"J Clin Microbiol"},{"key":"328_CR17","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1378\/chest.124.6.2395","volume":"124","author":"CA Hage","year":"2003","unstructured":"Hage CA, Wood KL, Winer-Muram HT, Wilson SJ, Sarosi G, Knox KS (2003) Pulmonary cryptococcosis after initiation of anti-tumor necrosis factor-alpha therapy. Chest 124:2395\u20132397","journal-title":"Chest"},{"key":"328_CR18","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S0161-6420(88)33192-1","volume":"95","author":"PW Hiss","year":"1988","unstructured":"Hiss PW, Shields JA, Augsburger JJ (1988) Solitary retinovitreal abscess as the initial manifestation of cryptococcosis. Ophthalmology 95:162\u2013165","journal-title":"Ophthalmology"},{"key":"328_CR19","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1128\/jcm.16.1.22-29.1982","volume":"16","author":"R Ikeda","year":"1982","unstructured":"Ikeda R, Shinoda T, Fukazawa Y, Kaufman L (1982) Antigenic characterization of Cryptococcus neoformans serotypes and its application to serotyping of clinical isolates. J Clin Microbiol 16:22\u201329","journal-title":"J Clin Microbiol"},{"key":"328_CR20","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1097\/QCO.0b013e3283177f6c","volume":"21","author":"JN Jarvis","year":"2008","unstructured":"Jarvis JN, Dromer F, Harrison TS, Lortholary O (2008) Managing cryptococcosis in the immunocompromised host. Curr Opin Infect Dis 21:596\u2013603","journal-title":"Curr Opin Infect Dis"},{"key":"328_CR21","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.1128\/JCM.36.10.2874-2876.1998","volume":"36","author":"CJ Jessup","year":"1998","unstructured":"Jessup CJ, Pfaller MA, Messer SA et al (1998) Fluconazole susceptibility testing of Cryptococcus neoformans: comparison of two broth microdilution methods and clinical correlates among isolates from Ugandan AIDS patients. J Clin Microbiol 36:2874\u20132876","journal-title":"J Clin Microbiol"},{"key":"328_CR22","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.ijid.2004.12.004","volume":"10","author":"S Kiertiburanakul","year":"2006","unstructured":"Kiertiburanakul S, Wirojtananugoon S, Pracharktam R, Sungkanuparph S (2006) Cryptococcosis in human immunodeficiency virus-negative patients. Int J Infect Dis 10:72\u201378","journal-title":"Int J Infect Dis"},{"issue":"111","key":"328_CR23","doi-asserted-by":"publisher","first-page":"125","DOI":"10.7326\/0003-4819-111-2-125","volume":"15","author":"RA Larsen","year":"1989","unstructured":"Larsen RA, Bozzette S, McCutchan JA et al (1989) Persistent Cryptococcus neoformans infection of the prostate after successful treatment of meningitis. California Collaborative Treatment Group. Ann Intern Med 15(111):125\u2013128","journal-title":"Ann Intern Med"},{"key":"328_CR24","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1046\/j.1439-0507.2003.00861.x","volume":"46","author":"J Liou","year":"2003","unstructured":"Liou J, Chiu C, Tseng C, Chi C, Fu L (2003) Cryptococcal meningitis in pediatric systemic lupus erythematosus. Mycoses 46:153\u2013156","journal-title":"Mycoses"},{"key":"328_CR25","doi-asserted-by":"publisher","first-page":"173","DOI":"10.4161\/viru.18685","volume":"3","author":"TB Liu","year":"2012","unstructured":"Liu TB, Perlin DS, Xue C (2012) Molecular mechanisms of cryptococcal meningitis. Virulence 3:173\u2013181","journal-title":"Virulence"},{"key":"328_CR26","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1093\/jac\/dkt221","volume":"68","author":"A Loyse","year":"2013","unstructured":"Loyse A, Dromer F, Day J, Lortholary O, Harrison TS (2013) Flucytosine and cryptococcosis: time to urgently address the worldwide accessibility of a 50-year-old antifungal. J Antimicrob Chemother 68:2435\u20132444","journal-title":"J Antimicrob Chemother"},{"key":"328_CR27","doi-asserted-by":"publisher","first-page":"2522","DOI":"10.1128\/JCM.00502-11","volume":"49","author":"L McTaggart","year":"2011","unstructured":"McTaggart L, Richardson SE, Seah C et al (2011) Rapid identification of Cryptococcus neoformans var. grubii, C. neoformans var. neoformans, and C. gattii by use of rapid biochemical tests, differential media, and DNA sequencing. J Clin Microbiol 49:2522\u20132527","journal-title":"J Clin Microbiol"},{"key":"328_CR28","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1093\/clinids\/22.5.838","volume":"22","author":"F Menichetti","year":"1996","unstructured":"Menichetti F, Fiorio M, Tosti A et al (1996) High-dose fluconazole therapy for cryptococcal meningitis in patients with AIDS. Clin Infect Dis 22:838\u2013840","journal-title":"Clin Infect Dis"},{"key":"328_CR29","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1111\/j.1365-4632.2008.03137.x","volume":"47","author":"EA Moosbrugger","year":"2008","unstructured":"Moosbrugger EA, Adams BB, Kralovic SM (2008) Cutaneous cryptococcosis in a patient on corticosteroid therapy for rheumatoid arthritis. Int J Dermatol 47:630\u2013632","journal-title":"Int J Dermatol"},{"key":"328_CR30","doi-asserted-by":"crossref","first-page":"4564","DOI":"10.1128\/iai.65.11.4564-4571.1997","volume":"65","author":"JW Murphy","year":"1997","unstructured":"Murphy JW, Zhou A, Wong SC (1997) Direct interactions of human natural killer cells with Cryptococcus neoformans inhibit granulocyte-macrophage colony-stimulating factor and tumor necrosis factor alpha production. Infect Immun 65:4564\u20134571","journal-title":"Infect Immun"},{"key":"328_CR31","doi-asserted-by":"publisher","first-page":"e83","DOI":"10.1086\/425121","volume":"39","author":"MG Netea","year":"2004","unstructured":"Netea MG, Brouwer AE, Hoogendoorn EH et al (2004) Two patients with cryptococcal meningitis and idiopathic CD4 lymphopenia: defective cytokine production and reversal by recombinant interferon-gamma therapy. Clin Infect Dis 39:e83\u2013e87","journal-title":"Clin Infect Dis"},{"key":"328_CR32","first-page":"852","volume":"89","author":"L Pagano","year":"2004","unstructured":"Pagano L, Fianchi L, Caramatti C et al (2004) Cryptococcosis in patients with hematologic malignancies. A report from GIMEMA-infection. Haematologica 89:852\u2013856","journal-title":"Haematologica"},{"key":"328_CR33","first-page":"61","volume":"124","author":"PG Pappas","year":"2013","unstructured":"Pappas PG (2013) Cryptococcal infections in non-HIV-infected patients. Trans Am Clin Climatol Assoc 124:61\u201379","journal-title":"Trans Am Clin Climatol Assoc"},{"key":"328_CR34","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1086\/322597","volume":"33","author":"PG Pappas","year":"2001","unstructured":"Pappas PG, Perfect JR, Cloud GA et al (2001) Cryptococcosis in human immunodeficiency virus-negative patients in the era of effective azole therapy. Clin Infect Dis 33:690\u2013699","journal-title":"Clin Infect Dis"},{"key":"328_CR35","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1097\/QAD.0b013e328322ffac","volume":"23","author":"BJ Park","year":"2009","unstructured":"Park BJ, Wannemuehler KA, Marston BJ, Govender N, Pappas PG, Chiller TM (2009) Estimation of the current global burden of cryptococcal meningitis among persons living with HIV\/AIDS. AIDS 23:525\u2013530","journal-title":"AIDS"},{"key":"328_CR36","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1086\/649858","volume":"50","author":"JR Perfect","year":"2010","unstructured":"Perfect JR, Dismukes WE, Dromer F et al (2010) Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of America. Clin Infect Dis 50:291\u2013322","journal-title":"Clin Infect Dis"},{"key":"328_CR37","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1111\/j.1600-0404.1989.tb03930.x","volume":"80","author":"NA Peterslund","year":"1989","unstructured":"Peterslund NA, Black FT, Geil JP, Mogensen CE (1989) Beta-2-microglobulin in the cerebrospinal fluid of patients with infections of the central nervous system. Acta Neurol Scand 80:579\u2013583","journal-title":"Acta Neurol Scand"},{"key":"328_CR38","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1128\/JCM.43.5.2163-2167.2005","volume":"43","author":"MA Pfaller","year":"2005","unstructured":"Pfaller MA, Messer SA, Boyken L et al (2005) Global trends in the antifungal susceptibility of Cryptococcus neoformans (1990 to 2004). J Clin Microbiol 43:2163\u20132167","journal-title":"J Clin Microbiol"},{"key":"328_CR39","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1086\/342384","volume":"35","author":"JH Rex","year":"2002","unstructured":"Rex JH, Pfaller MA (2002) Has antifungal susceptibility testing come of age? Clin Infect Dis 35:982\u2013989","journal-title":"Clin Infect Dis"},{"key":"328_CR40","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1128\/CMR.6.4.367","volume":"6","author":"JH Rex","year":"1993","unstructured":"Rex JH, Pfaller MA, Rinaldi MG, Polak A, Galgiani JN (1993) Antifungal susceptibility testing. Clin Microbiol Rev 6:367\u2013381","journal-title":"Clin Microbiol Rev"},{"key":"328_CR41","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1128\/CMR.14.4.643-658.2001","volume":"14","author":"JH Rex","year":"2001","unstructured":"Rex JH, Pfaller MA, Walsh TJ et al (2001) Antifungal susceptibility testing: practical aspects and current challenges. Clin Microbiol Rev 14:643\u2013658","journal-title":"Clin Microbiol Rev"},{"key":"328_CR42","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1157\/13093886","volume":"24","author":"A Riera-Mestre","year":"2006","unstructured":"Riera-Mestre A, de la Haba-Vacas I, Vidaller-Palac\u00edn A, Fern\u00e1ndez-Viladrich P (2006) Infecci\u00f3n criptoc\u00f3cica y tratamiento inmunosupresor. Enferm Infecc Microbiol Clin 24:595","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"328_CR43","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1086\/313757","volume":"30","author":"MS Saag","year":"2000","unstructured":"Saag MS, Graybill RJ, Larsen RA et al (2000) Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America. Clin Infect Dis 30:710\u2013718","journal-title":"Clin Infect Dis"},{"key":"328_CR44","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1111\/j.1365-2141.2007.06781.x","volume":"139","author":"RB Salit","year":"2007","unstructured":"Salit RB, Hankey KG, Yi R, Rapoport AP, Mann DL (2007) Detection of CD4(+) T-cell antibodies in a patient with idiopathic CD4 T lymphocytopenia and cryptococcal meningitis. Br J Haematol 139:133\u2013137","journal-title":"Br J Haematol"},{"key":"328_CR45","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1093\/rheumatology\/keg432","volume":"43","author":"A Schattner","year":"2004","unstructured":"Schattner A, Friedman J, Bentwich Z (2004) Opportunistic infection due to unexplained CD4+ lymphocytopenia and associated Sj\u00f6gren's syndrome. Rheumatology (Oxford) 43:111\u2013112","journal-title":"Rheumatology (Oxford)"},{"key":"328_CR46","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.ijantimicag.2007.07.019","volume":"30","author":"PL Shao","year":"2007","unstructured":"Shao PL, Huang LM, Hsueh PR (2007) Recent advances and challenges in the treatment of invasive fungal infections. Int J Antimicrob Agents 30:487\u2013495","journal-title":"Int J Antimicrob Agents"},{"key":"328_CR47","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/j.1365-2141.2005.05397.x","volume":"129","author":"S Shoham","year":"2005","unstructured":"Shoham S, Levitz SM (2005) The immune response to fungal infections. Br J Haematol 129:69\u201382","journal-title":"Br J Haematol"},{"key":"328_CR48","doi-asserted-by":"publisher","first-page":"2793","DOI":"10.1128\/AAC.00216-13","volume":"57","author":"A Sudan","year":"2013","unstructured":"Sudan A, Livermore J, Howard SJ et al (2013) Pharmacokinetics and pharmacodynamics of fluconazole for cryptococcal meningoencephalitis: implications for antifungal therapy and in vitro susceptibility breakpoints. Antimicrob Agents Chemother 57:2793\u20132800","journal-title":"Antimicrob Agents Chemother"},{"key":"328_CR49","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/S0387-7604(99)00017-0","volume":"21","author":"S Takahashi","year":"1999","unstructured":"Takahashi S, Oki J, Miyamoto A et al (1999) Beta-2-microglobulin and ferritin in cerebrospinal fluid for evaluation of patients with meningitis of different etiologies. Brain Dev 21:192\u2013199","journal-title":"Brain Dev"},{"key":"328_CR50","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1111\/j.1439-0507.1997.tb00235.x","volume":"40","author":"AM Tortorano","year":"1997","unstructured":"Tortorano AM, Viviani MA, Rigoni AL et al (1997) Prevalence of serotype D in Cryptococcus neoformans isolates from HIV positive and HIV negative patients in Italy. Mycoses 40:297\u2013302","journal-title":"Mycoses"},{"key":"328_CR51","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1097\/01.bor.0000231908.57913.2f","volume":"18","author":"UA Walker","year":"2006","unstructured":"Walker UA, Warnatz K (2006) Idiopathic CD4 lymphocytopenia. Curr Opin Rheumatol 18:389\u2013395","journal-title":"Curr Opin Rheumatol"},{"key":"328_CR52","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1093\/clinids\/22.2.322","volume":"22","author":"MD Witt","year":"1996","unstructured":"Witt MD, Lewis RJ, Larsen RA et al (1996) Identification of patients with acute AIDS-associated cryptococcal meningitis who can be effectively treated with fluconazole: the role of antifungal susceptibility testing. Clin Infect Dis 22:322\u2013328","journal-title":"Clin Infect Dis"},{"key":"328_CR53","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1080\/13693780410001731628","volume":"43","author":"Z Yao","year":"2005","unstructured":"Yao Z, Liao W, Chen R (2005) Management of cryptococcosis in non-HIV-related patients. Med Mycol 43:245\u2013251","journal-title":"Med Mycol"},{"key":"328_CR54","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1097\/md.0b013e31803b52f5","volume":"86","author":"DI Zonios","year":"2007","unstructured":"Zonios DI, Falloon J, Huang CY, Chaitt D, Bennett JE (2007) Cryptococcosis and idiopathic CD4 lymphocytopenia. Medicine (Baltimore) 86:78\u201392","journal-title":"Medicine (Baltimore)"}],"container-title":["Folia Microbiologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12223-014-0328-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12223-014-0328-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12223-014-0328-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12223-014-0328-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T04:35:02Z","timestamp":1744173302000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12223-014-0328-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,20]]},"references-count":54,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["328"],"URL":"https:\/\/doi.org\/10.1007\/s12223-014-0328-0","relation":{},"ISSN":["0015-5632","1874-9356"],"issn-type":[{"type":"print","value":"0015-5632"},{"type":"electronic","value":"1874-9356"}],"subject":[],"published":{"date-parts":[[2014,6,20]]},"assertion":[{"value":"30 August 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}